Thursday - March 06, 2025

Oligonucleotide Synthesis Market worth $19.7 billion by 2029 | MarketsandMarkets™

The North American market is projected to grow at the highest CAGR during the Forecast Oligonucleotide Synthesis Market Size by Product (Drugs (ASO, siRNA), Synthesized Oligo (Primer), Reagents, Equipment), Type (Custom, Predesigned), Application (Therapeutic (Neurology, Rare), Research (PCR, Sequencing), Diagnostics) … Continue reading

Metastatic Melanoma Pipeline 2024: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Evaxion Biotech, InxMed, AiVita Biomedical, Apexigen, Checkmate Pharma, Nektar therapeutic

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Metastatic Melanoma pipeline constitutes 75+ key companies continuously working towards developing 75+ Metastatic Melanoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

BRAF Mutated Non-small Cell Lung Cancer Market Predicted to See Upsurge Through 2032, Highlights DelveInsight | AbbVie, Xcovery, Sanofi, NeoImmune Tech, Merck KGaA and Pfizer, Mirati Therapeutics

The Key BRAF Mutated Non-small Cell Lung Cancer Companies in the market include – AbbVie, Xcovery, Sanofi, NeoImmune Tech, Merck KGaA and Pfizer, Mirati Therapeutics, AstraZeneca, Daiichi Sankyo, Inc., Gilead Sciences, Merck Sharp & Dohme LLC, Arcus Biosciences, Inc., Ono … Continue reading

Nk Cell Therapy Pipeline 2024: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Artiva Biotherapeutics, Dragonfly therapeutics, Affimed, XNK Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Nk Cell Therapy pipeline constitutes 140+ key companies continuously working towards developing 160+ Nk Cell Therapy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading